Elevated plasma nitric oxide metabolites in hypertension: Synergistic vasodepressor effects of a static magnetic field and nicardipine in spontaneously hypertensive rats

Clinical Hemorheology and Microcirculation

Volumn 34, Issue 1-2, 2006, Pages 303-308

  Okano, Hideyuki ^a,b   Ohkubo, Chiyoji ^a  

^a NATIONAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^b Department of Sciences   (Japan)

Author keywords

Antihypertensive effects; Baroreceptor; Ca2+ channel blocker; Nitric oxide; Spontaneously hypertensive rats; Static magnetic fields

Indexed keywords

CALCIUM CHANNEL L TYPE; NICARDIPINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CALCIUM TRANSPORT; CAROTID SINUS; CONFERENCE PAPER; CONTROLLED STUDY; HEART RATE; HYPERTENSION; MAGNETIC FIELD; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; RAT; SKIN BLOOD FLOW;

ANIMALS; BLOOD PRESSURE; CALCIUM CHANNELS; HEART RATE; HYPERTENSION; MAGNETICS; NICARDIPINE; NITRIC OXIDE; PRESSORECEPTORS; RATS; RATS, INBRED SHR; REGIONAL BLOOD FLOW; SKIN;

EID: 33644814527     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. S.G. Ivanov, V.V. Smirnov, F.V. Solov'eva, S.P. Liashevskaia and L.Iu. Selezneva, The magnetotherapy of hypertension patients, Ter. Arkh. 62 (1990), 71-74.
2. S.G. Ivanov, The comparative efficacy of nondrug and drug methods of treating hypertension, Ter. Arkh. 65 (1993), 44-49.
3. H. Okano, H. Masuda and C. Ohkubo, Decreased plasma levels of nitric oxide metabolites, angiotensin II and aldosterone in spontaneously hypertensive rats exposed to 5 mT static magnetic field, Bioelectromagnetics 26 (2005), 161-172.
4. J. Gmitrov and C. Ohkubo, Artificial static and geomagnetic field interrelated impact on cardiovascular regulation, Bioelectromagnetics 23 (2002), 329-338.
5. J. Gmitrov and C. Ohkubo, Verapamil protective effect on natural and artificial magnetic field cardiovascular impact, Bioelectromagnetics 23 (2002), 531-541.
6. H. Okano and C. Ohkubo, Modulatory effects of static magnetic fields on blood pressure in rabbits, Bioelectromagnetics 22 (2001), 408-418.
7. H. Okano and C. Ohkubo, Anti-pressor effects of whole-body exposure to static magnetic field on pharmacologically induced hypertension in conscious rabbits, Bioelectromagnetics 24 (2003), 139-147.
8. H. Okano and C. Ohkubo, Effects of static magnetic fields on plasma levels of angiotensin II and aldosterone associated with arterial blood pressure in genetically hypertensive rats, Bioelectromagnetics 24 (2003), 403-412.
9. H. Okano and C. Ohkubo, Effects of neck exposure to 5.5 mT static magnetic field on pharmacologically modulated blood pressure in conscious rabbits, Bioelectromagnetics 26 (2005), 469-480.
10. H.M. Lee, G. Wang, E.W. Englander, M. Kojima and G.H. Greeley Jr., Ghrelin, a new gastrointestinal endocrine peptide that stimulates insulin secretion: enteric distribution, ontogeny, influence of endocrine, and dietary manipulations, Endocrinology 143 (2002), 185-190.
11. S. Hidaka, B. Kranzlin, N. Gretz and R. Witzgall, Urinary clusterin levels in the rat correlate with the severity of tubular damage and may help to differentiate between glomerular and tubular injuries, Cell Tissue Res. 310 (2002), 289-296.
12. L.C. Green, D.A. Wagner, J. Glogowski, P.L. Skipper, J.S. Wishnok and S.R. Tannenbaum, Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids, Anal. Biochem. 126 (1982), 131-138.
13. I. Guevara, J. Iwanejko, A. Dembińska-Kieć, J. Pankiewicz, A. Wanat, P. Anna, I. Goła̧bek, S. Bartuś, M. Malczewska-Malec and A. Szczudlik, Determination of nitrite/nitrate in human biological material by the simple Griess reaction, Clin. Chim. Acta 274 (1998), 177-188.
14. T.C. Chou, M.H. Yen, C.Y. Li and Y.A. Ding, Alterations of nitric oxide synthase expression with aging and hypertension in rats, Hypertension 31 (1998), 643-648.
15. S.W. Kim, K.H. Moon, S.C. Lee, N.H. Kim, D.G. Kang, J.U. Lee, K.C. Choi and Y.J. Kang, Altered renal expression of nitric oxide synthase isozymes in spontaneously hypertensive rats, Korean J. Intern. Med. 14 (1999), 21-26.
16. X.L. Ma, F. Gao, A.H. Nelson, B.L. Lopez, T.A. Christopher, T.L. Yue and F.C. Barone, Oxidative inactivation of nitric oxide and endothelial dysfunction in stroke-prone spontaneous hypertensive rats. J. Pharmacol. Exp. Ther. 298 (2001), 879-885.
17. S. Bachmann, H.M. Bosse and P. Mundel, Topography of nitric oxide synthesis by localizing constitutive NO synthases in mammalian kidney, Am. J. Physiol. 268 (1995), F885-F898.
18. C.S. Wilcox, X. Deng and W.J. Welch, NO generation and action during changes in salt intake: Roles of nNOS and macula densa, Am. J. Physiol. 274 (1998), R1588-1593.
19. W.J. Welch, A. Tojo, J.U. Lee, D.G. Kang, C.G. Schnackenberg and C.S. Wilcox, Nitric oxide synthase in the JGA of the SHR: Expression and role in tubuloglomerular feedback, Am. J. Physiol. 277 (1999), F130-138.
20. A. Berdeaux, Nitric oxide: an ubiquitous messenger, Fundam. Clin. Pharmacol. 7 (1993), 401-411.